An Assessment of Statin Safety by Neurologists
- 17 April 2006
- journal article
- practice guideline
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (8) , S86-S88
- https://doi.org/10.1016/j.amjcard.2005.12.017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Atorvastatin for the Treatment of Mild to Moderate Alzheimer DiseaseArchives of Neurology, 2005
- Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databasesJournal of Epidemiology and Community Health, 2004
- Statin‐Associated Peripheral Neuropathy: Review of the LiteraturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditionsThe Lancet, 2004
- Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the LiteraturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialThe Lancet, 2002
- Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trialAnnals of Neurology, 2002
- Statins and risk of polyneuropathyNeurology, 2002
- Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?European Journal of Clinical Pharmacology, 2001
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998